119 related articles for article (PubMed ID: 2545434)
1. [Toxophilic effects of morphinomimetic substances. Dopamine/enkephalin interactions in the ventral tegmental area and in the nucleus accumbens].
Stinus L; Cesselin F; Deminière JM; Bourgouin S; Hamon M; Le Moal M
Encephale; 1989; 15 Spec No():95-104. PubMed ID: 2545434
[No Abstract] [Full Text] [Related]
2. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat.
Mucha RF; Iversen SD
Brain Res; 1986 Nov; 397(2):214-24. PubMed ID: 3026557
[TBL] [Abstract][Full Text] [Related]
3. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.
Vezina P; Kalivas PW; Stewart J
Brain Res; 1987 Aug; 417(1):51-8. PubMed ID: 3040185
[TBL] [Abstract][Full Text] [Related]
4. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
Latimer LG; Duffy P; Kalivas PW
J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
[TBL] [Abstract][Full Text] [Related]
5. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
Noel MB; Gratton A
Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972
[TBL] [Abstract][Full Text] [Related]
6. [Effects of procaine and apomorphine injected into the ventral tegmental area on self-stimulation of the nucleus accubens (author's transl)].
Takigawa M; Mogenson GJ
No To Shinkei; 1980 Apr; 32(4):407-16. PubMed ID: 7378205
[TBL] [Abstract][Full Text] [Related]
7. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
Kalivas PW; Richardson-Carlson R; Duffy P
J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
Klitenick MA; Wirtshafter D
J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
[TBL] [Abstract][Full Text] [Related]
9. Modulation of dopamine-induced hypermotility following injection of various opioids into the nucleus accumbens.
Erdö F; Polgár K; Máté I; Székely JI
Acta Physiol Hung; 1990; 76(3):219-27. PubMed ID: 1966032
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement.
Bozarth MA; Wise RA
NIDA Res Monogr; 1986; 67():190-6. PubMed ID: 3092066
[No Abstract] [Full Text] [Related]
11. Intracranial self-administration of the endocoid methionine-enkephalin.
Goeders NE; Smith JE; Lane JD
J Am Osteopath Assoc; 1984 Sep; 84(1 Suppl):148-51. PubMed ID: 6092304
[No Abstract] [Full Text] [Related]
12. Central integration of cardiovascular and drinking responses elicited by central administration of angiotensin II: divergence of regulation by the ventral tegmental area and nucleus accumbens.
Jones DL
Can J Physiol Pharmacol; 1986 Jul; 64(7):1011-6. PubMed ID: 3768792
[TBL] [Abstract][Full Text] [Related]
13. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
Calenco-Choukroun G; Daugé V; Gacel G; Roques BP
Eur J Pharmacol; 1991 Dec; 209(3):267-71. PubMed ID: 1665799
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
Altier N; Stewart J
J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
[TBL] [Abstract][Full Text] [Related]
15. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
[TBL] [Abstract][Full Text] [Related]
16. Lesions of the nucleus accumbens in rats reduce opiate reward but do not alter context-specific opiate tolerance.
Kelsey JE; Carlezon WA; Falls WA
Behav Neurosci; 1989 Dec; 103(6):1327-34. PubMed ID: 2558677
[TBL] [Abstract][Full Text] [Related]
17. The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus.
Joyce EM; Koob GF; Strecker R; Iversen SD; Bloom FE
Brain Res; 1981 Sep; 221(2):359-70. PubMed ID: 7025963
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
Klitenick MA; Kalivas PW
J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
[TBL] [Abstract][Full Text] [Related]
19. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.
Kalivas PW; Abhold R
Brain Res; 1987 Jun; 414(2):339-48. PubMed ID: 3620936
[TBL] [Abstract][Full Text] [Related]
20. Endogenous enkephalin modulation of dopamine neurons in ventral tegmental area.
Kalivas PW; Richardson-Carlson R
Am J Physiol; 1986 Aug; 251(2 Pt 2):R243-9. PubMed ID: 3017134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
